Name: Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation (Video) | JoVE Journal
Uploaded: 2025-08-26T15:00:00.000+00:00
Duration: 9 min 56 s
Description: Discover the I-GONAD method for generating knockout mice using in utero electroporation and CRISPR/Cas9 technology. This approach reduces animal use while achieving efficiency comparable to traditional microinjection techniques.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

Authors are grateful to St Peterburg University Research Park, Center for Molecular and Cell Technologies. Sequencing was performed using an ABI 3500 xL Genetic Analyzer (Thermo Fisher Scientific, USA) at the Resource Center of Molecular and Cell Technologies, Saint Petersburg State University Scientific Park. The authors are grateful to Maria Rubel for her help in editing and submitting the documents. This research was funded by Saint Petersburg State University, research project ID: 129658320, and Luibov Shkodenko was supported by the Russian Scientific Foundation (project 25-26-00247).

All animal studies were approved by the Animal Research Ethics Committee of Saint Petersburg State University (Approval No. 131-03-5, October 11, 2022). All procedures strictly adhered to the guidelines outlined in the Guide for the Care and Use of Laboratory Animals. Common laboratory outbred strain CD1 mice were obtained from the Collective Use Center of the Institute of Physiologically Active Compounds, Russian Academy of Sciences (IPAC RAS). Female CD1 mice aged 2-3 months (average weight 27-30 g) were used for mating with male CD1 mice aged 2.5-4 months (average weight 35-37 g). The reagents and the equipment used in this study are listed in the Table of Materials.
1. Single-guide RNA (sgRNA) design and its preparation for transfection
<ol>
	<li>Use computational analysis tools like CHOPCHOP, SYNTHEGO Knockout Guide Design, or CRISPOR to identify potential sgRNA sequences targeting the selected gene of interest. 
	NOTE: The software can identify potential sgRNA sequences throughout the whole gene and suggests multiple variants at the output. These tools will suggest the most optimal sgRNA options and will allow the user to choose among all identified variants if needed. When making a selection, consider the following criteria:
	<ol>
		<li>Exon proximity: Choose sequences located in exons that are as close as possible to the desired mutation point. For better results, consider the alternative splice isoforms and select the target sequence that is present in the most isoforms. Consider genome browsers (e.g., Ensembl) for accurate exon selection.</li>
		<li>Off-target considerations: Analyze potential off-target effects using the tool&#39;s scoring system, selecting sequences that exhibit the lowest predicted off-target activity. 
		NOTE: Computational tools like CHOPCHOP or Synthego are highly effective for assessing exon proximity and off-target effects, helping to identify optimal sgRNA sequences for precise genome editing. When designing guide RNAs, it is important to consider the specific sequence of the gene of interest in the mouse strain being used. For some mouse strains (e.g., C57Bl, CBA, C3H), the full genomic sequence is available. If such data are unavailable, it may be advisable to perform preliminary sequencing of the target gene in the planned editing region. Single mismatches in the guide RNA, caused by polymorphisms, may compromise editing efficiency. The ROSA 26 mouse genome locus was targeted with the sgRNA sequence: 5&#39;-ACTCCAGTCTTTCTAGAAGA-3&#39;.</li>
	</ol>
	</li>
	<li>Order a set of primers for sgRNA template PCR-amplification as described in Table 1. 
	NOTE: gRNA can be ordered elsewhere, either as sgRNA or as crRNA:tracrRNA duplex.</li>
	<li>Produce a linear dsDNA template.
	<ol>
		<li>Prepare the master mix as indicated in Table 1. Add the polymerase at the end and keep the master mix on ice to maintain stability.</li>
		<li>Run the PCR under the following conditions: Initial denaturation: 30 s at 95 &#176;C; 30 cycles of: 20 s at 95 &#176;C (denaturation), 20 s at 55 &#176;C (annealing), 15 s at 72 &#176;C (extension); Final elongation: 2 min at 72 &#176;C; Hold at 4 &#176;C.</li>
	</ol>
	</li>
	<li>Use the PCR reaction mixture in further In Vitro Transcription (IVT) reaction.
	<ol>
		<li>Prepare the IVT master mix as indicated in Table 2 and incubate for 1.5 h at 37 &#176;C. Use a thermocycler for consistent temperature control.</li>
		<li>Add 2 &#181;L of DNase I and incubate for another 30 min at 37 &#176;C to remove the DNA template.</li>
		<li>Inactivate DNase I by incubating the reaction mixture at 75 &#176;C for 5 min.</li>
		<li>Purify RNA using TRIZOL reagent according to the manufacturer&#39;s protocol. 
		NOTE: Disposal of the TRIZOL reagent and DNAse1, its solutions, or any by-products, should be placed in designated chemical waste containers.</li>
		<li>Measure the RNA concentration using a spectrophotometer (the typical yield of one reaction is 3-5 &#181;g). Check the A260/ A280 and A260/A230 ratios. A260/ A280 should be at least 2.0, and the A260/A230 ratio should also be at least 2.0 (meaning there is no contamination by proteins or organic solvents). Store the sgRNAs at -80 &#176;C until use.</li>
	</ol>
	</li>
	<li>Prepare the RNP mix for transfection
	<ol>
		<li>The transfection mix consists of an RNP complex, which is a mixture of the Cas9 protein and sgRNA. Follow these steps to prepare the RNP mix:</li>
		<li>Dilute 1 M Tris-HCl (pH 7.5) buffer to 100 mM using nuclease-free water and filter using a syringe filter with 0.022 &#181;M pore size, aliquot in 10 &#181;L portions, and store at 4 &#176;C until use.</li>
		<li>In a nuclease-free tube, prepare the transfection mix of the following components in the final concentrations: 500 ng/&#181;L spCas9 nuclease, 80 ng/&#181;L sgRNA, 10 mM Tris-HCl diluted with DEPC-treated water. 
		NOTE: High concentrations of the RNP mix components are required to ensure proper efficiency of the protocol.</li>
		<li>Incubate the transfection mix at 37 &#176;C for 10 min to allow the formation of the RNP complex.</li>
		<li>Aliquot the mix into small volumes (2 &#181;L) suitable for a single I-GONAD session.</li>
		<li>Keep the aliquots at 4 &#176;C during the I-GONAD session. The mix is prepared fresh for each I-GONAD electroporation session to maintain stability. 
		NOTE: The RNP mix should be prepared fresh for each I-GONAD session to ensure optimal activity and efficiency.</li>
	</ol>
	</li>
</ol>
2. Preparation of female mice for genome editing via oviductal nucleic acid delivery
<ol>
	<li>Mating and selection of female mice: Mate CD1 female mice with single-housed CD1 male mice overnight. In the morning, check for the presence of copulation plugs in the female mice. Select females with copulation plugs and transfer them to a new cage for further procedures. 
	NOTE: To minimize genetic mosaicism, the optimal time for delivering the genetic construct is 0.7 days post-mating at the single-cell (zygote) stage10. This approximately corresponds to 16:00 p.m. on the day when the copulation plug was detected. At this stage, dissection of the oviduct reveals that zygotes have fewer cumulus cells, though they remain in the ampulla. Notably, cumulus cells can also take up exogenous nucleic acids or proteins during electroporation. If the procedure is performed earlier, for example, at 10 h post-mating, the cumulus cells still tightly surround the zygotes, which may hinder efficient electrophoretic delivery of nucleic acids into the zygotes. Do not use the hormonally stimulated mice, since they might give an excessive number of oocytes, and this might lead to miscarriage.</li>
	<li>Preparation of surgical instruments: Autoclave all stainless-steel surgical instruments to ensure sterility. All non-stainless steel items that come in contact with the mouse&#39;s internal organs should be provided as sterile or single-use items.</li>
	<li>Analgesia, anesthesia and preparation of mice: Weigh the selected female mice and apply meloxicam solution (5 mg/kg, s.c.) 15 min prior to anesthesia induction. Anesthetize mice via intraperitoneal injection using a mixture of ketamine (100 mg/kg) and xylazine (10 mg/kg) (following institutionally approved protocols).
	<ol>
		<li>Monitor the mice for loss of the toe pinch reflex to confirm adequate anesthesia. Place the anesthetized mouse on a heating pad to maintain body temperature during the procedure. Protect the mouse&#39;s eyes from dryness during anesthesia by applying veterinary ointment.</li>
	</ol>
	</li>
</ol>
3. Surgical procedure
<ol>
	<li>Remove hair from the surgical area and disinfect the skin with a chlorhexidine or betadine scrub or solution, followed by 70% ethanol in 3 alternating passes.</li>
	<li>Make a 0.7 cm longitudinal skin incision in the lower back region..</li>
	<li>Extend the incision to 1.3 cm by pushing laterally with slightly opened scissor tips.</li>
	<li>Carefully make a small incision (0.7 cm) in the peritoneum to access the abdominal cavity.</li>
	<li>Extend the incision to 1.1 cm by pushing laterally with slightly opened scissor tips.</li>
	<li>Locate the fat pad attached to the ovary and gently pull it out using forceps until the ovary, oviduct, and uterus are clearly visible.</li>
	<li>Secure the fat pad in place using a vessel clamp.</li>
	<li>Visualize the oviduct under a stereoscopic microscope for precise manipulation (Figure 1).</li>
	<li>Load 2 &#181;L of the injection mix into a sterile plastic capillary using a Stripper Pipettor. 
	NOTE: The Stripper Pipettor with sterile plastic capillaries, originally designed for manipulations with embryos in IVF clinics, can support multiple applications, including embryo transfer and CRISPR/Cas9 construct delivery in I-GONAD procedures. The pipettor functions as a precision liquid dispenser; in combination with sterile disposable flexible capillaries, it allows sterility and prevents cross-contamination. Plastic capillaries are preferable to glass for injecting RNP mix for transfection into the oviduct, as they are less traumatic to delicate tissues. Unlike glass capillaries, disposable plastic ones do not require flame-polishing to smooth sharp edges before insertion, reducing preparation time and risk of damage.</li>
	<li>Using micro-scissors, make a small incision (0.2 cm) in the oviduct wall a few millimeters upstream of the ampulla.</li>
	<li>Carefully insert the Stripper Pipettor with plastic capillary into the incision and expel the injection mix into the oviduct. 
	NOTE: Ensure that no air enters the oviduct, as this may affect the efficiency of electroporation. 
	To prevent this, fill the injection plastic capillary with more injection mix than necessary and avoid complete injection. Plastic capillaries are suitable for both infundibulum transfer and direct oviduct wall dissection between the infundibulum and ampulla. The direct oviduct wall dissection method might be less traumatic than infundibulum transfer since the latter requires an initial incision through the thin bursa membrane covering the oviduct and infundibulum. In CD1 mice, this membrane is highly vascularized, and cutting it may cause minor bleeding, which can obstruct visibility and complicate microinjection of the RNP mix.</li>
	<li>Gently remove the plastic capillary from the oviduct.</li>
</ol>
4. Electroporation and suturing
<ol>
	<li>Turn on the electroporator by pushing the switch on the front panel.</li>
	<li>Set electroporation parameters: Poring pulse: Voltage: 50 V, Pulse length: 5 m, Pulse interval: 50 ms, Number of pulses: 3, Decay rate - 10%, Polarity: +/-; Transfer pulse: Voltage: 10 V, Pulse length: 50 ms, Pulse interval: 50 ms, Number of pulses: 3, Decay rate - 40%, Polarity: +/-; Current limit: in vivo.</li>
	<li>Using the tweezer-type electrodes, carefully grasp the oviduct and check the resistance value by pressing the k&#937; button on the electroporator. Ensure that the electrodes are compressed sufficiently so that the resistance remains within the optimal range of 350-400 &#937;. 
	NOTE: This can be achieved by adjusting the distance between the two electrodes when the intact oviduct is sandwiched between them.
	<ol>
		<li>Immediately after measuring the resistance, press the Start button to initiate electroporation. This step is critical to ensure efficient delivery of CRISPR-Cas components into the zygotes4. Wait for the &#937; button to display an &#34;end&#34; signal. Write down the values shown in the Measurements frame. 
		NOTE: The impedance value should be approximately 250-400 &#8486;/150-250 mA of the voltage value to ensure an optimal balance between viability and transfer efficiency. To maintain this balance, avoid the coverage of the oviduct regions with a piece of wet paper soaked in Dulbecco&#39;s modified phosphate-buffered saline (DPBS), recommended in some protocols, as this step can significantly decrease the resistance beyond the optimal range. Decreased resistance can raise the voltage to more than 250 mA, leading to cell death.</li>
	</ol>
	</li>
	<li>After completing electroporation on one oviduct, carefully place the reproductive tract back into the abdominal cavity. Suture the incision using 4-0 polyglycolic acid surgical suture.</li>
	<li>Repeat the operation and electroporation on the second oviduct. Once completed, return the reproductive tract to the abdominal cavity and suture the incision as described above.</li>
	<li>Post-procedure monitoring: Place the mouse in a warm (37&#160;&#176;C), clean cage for recovery and monitor until it fully recovers from anesthesia. 
	NOTE: After the surgery, house the mice in cages containing two mice per cage. If only one mouse underwent surgery, provide her with a companion female mouse. This practice helps to reduce unnecessary stress for the surgical mouse and promotes a more natural social environment. After 12 h, perform a second injection of analgesic (meloxicam, 5 mg/kg, s.c.).</li>
</ol>
5. Genotyping
<ol>
	<li>Primer design
	<ol>
		<li>For genotyping, design primers to amplify a PCR product between 300-600 bp in length. Primers should be 18-21 nucleotides long with a melting temperature (Tm) of approximately 60 &#176;C.</li>
		<li>Avoid sequences that form secondary structures or primer dimers. Use software tools such as PerlPrimer 1.1.2111, In-Silico PCR V39x1, or similar to ensure primer quality.</li>
		<li>Perform a BLAST search against the mouse genome database to confirm primer specificity and avoid non-specific amplification11. 
		NOTE: The following primers were designed for genotyping of the target sequence: Forward primer: 5&#39;-CTCTCCCAAAGTCGCTCTGA-3&#39;; Reverse primer: - 5&#39;-TCTGTGGGAAGTCTTGTCCC-3&#39;, expected PCR product length: 320 bp, and Tm 62&#176;C. For Sanger sequencing, design a sequencing primer that anneals 150-200 bp away from the Cas9 cut site.</li>
	</ol>
	</li>
	<li>Perform DNA extraction. For rapid DNA extraction, the Hotshot isolation protocol12 is the simplest one.
	<ol>
		<li>Using an ear punch, collect a small tissue fragment (approximately 2 mm) from the mouse&#39;s ear.</li>
		<li>Add 100 &#181;L of Lysis Buffer (25 mM NaOH, 0.2 mM EDTA, pH = 12).</li>
		<li>Incubate at 95 &#176;C for 60 min, vortexing the mixture every 20 min.</li>
		<li>Add 100 &#181;L of Neutralizing Buffer (40 mM Tris-HCl, pH = 5) and vortex thoroughly.</li>
		<li>Use 1-5 &#181;L of the final preparation for PCR.</li>
	</ol>
	</li>
	<li>PCR amplification and sequencing. Prepare the PCR master mix as outlined in Table 3. Use a proofreading DNA polymerase to ensure high fidelity. Aliquot the master mix into the required number of tubes and add genomic DNA. 
	NOTE: Always include a wild-type DNA sample as a control for sequencing analysis.</li>
	<li>Run the PCR for ROSA26 genotyping. The following conditions were used: Initial denaturation: 30 s at 95 &#176;C; 28 cycles of: 20 s at 95 &#176;C (denaturation), 20 s at 62 &#176;C (annealing), 20 s at 72 &#176;C (extension); Final elongation: 2 min at 72 &#176;C; Hold at 4 &#176;C. 
	NOTE: The provided protocol is accurate for ROSA26 locus fragment (estimated size 320 bp) amplification using primers from step 1.1.2. For more specific and accurate amplification, limit the number of amplification cycles to 28-30.</li>
	<li>Sequencing and analysis
	<ol>
		<li>Perform Sanger sequencing of PCR fragments obtained (step 5.4).</li>
		<li>Analysis of the sequencing results 
		NOTE: Successful transfection will result in mosaic animals, identifiable by the emergence of additional DNA sequences near the nuclease cut site in the sequencing chromatogram. Use computational tools such as EditCo ICE Analysis or TIDE13 to identify and quantify exact indels in the genome.
		<ol>
			<li>To use ICE Analysis, simply upload obtained Sanger sequencing files (control .ab1 file for wt mouse PCR product sequence with no editing and experiment .ab1 file for experiment mouse PCR product sequence), enter the guide RNA sequence, and select the nuclease used in the CRISPR experiment. 
			NOTE: The ICE Analysis tool will calculate the overall editing efficiency, and determine the profiles and relative abundances of all of the different types of edits present in the sample.</li>
			<li>To use TIDE, enter the guide RNA sequence, upload obtained Sanger sequencing files (control .ab1 file for wt mouse PCR product sequence with no editing and experiment .ab1 file for experiment mouse PCR product sequence), and check Parameters (in some cases, Advanced settings can help to find indels larger than 10 bp).</li>
		</ol>
		</li>
	</ol>
	</li>
</ol>

<ol><li>Fujihara, Y., Ikawa, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((CRISPR%2FCas9-Based+Genome+Editing+in+Mice+by+Single+Plasmid+Injection%5BTitle%5D)+AND+%22Methods+Enzymol%22%5BJournal%5D)">CRISPR/Cas9-Based Genome Editing in Mice by Single Plasmid Injection.</a> Methods Enzymol. 546, 319-336 (2014).</li>
<li>Zuo, E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((One-step+generation+of+complete+gene+knockout+mice+and+monkeys+by+CRISPR%2FCas9-mediated+gene+editing+with+multiple+sgRNAs%5BTitle%5D)+AND+%22Cell+Res%22%5BJournal%5D)">One-step generation of complete gene knockout mice and monkeys by CRISPR/Cas9-mediated gene editing with multiple sgRNAs.</a> Cell Res. 27 (7), 933-945 (2017).</li>
<li>Hubrecht, R. C., Carter, E. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+3Rs+and+humane+experimental+technique%3A+Implementing+change%5BTitle%5D)+AND+%22Animals%22%5BJournal%5D)">The 3Rs and humane experimental technique: Implementing change.</a> Animals. 9 (10), 754(2019).</li>
<li>Kobayashi, Y., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Modification+of+i-GONAD+suitable+for+production+of+genome-edited+C57BL%2F6+inbred+mouse+strain%5BTitle%5D)+AND+%22Cells%22%5BJournal%5D)">Modification of i-GONAD suitable for production of genome-edited C57BL/6 inbred mouse strain.</a> Cells. 9 (4), 957(2020).</li>
<li>Takabayashi, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Successful+i-GONAD+in+mice+at+early+zygote+stage+through+in+vivo+electroporation+three+minutes+after+intra-oviductal+instillation+of+CRISPR-ribonucleoprotein%5BTitle%5D)+AND+%22Int+J+Mol+Sci%22%5BJournal%5D)">Successful i-GONAD in mice at early zygote stage through in vivo electroporation three minutes after intra-oviductal instillation of CRISPR-ribonucleoprotein.</a> Int J Mol Sci. 23 (18), 10678(2022).</li>
<li>Sato, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Sequential+i-GONAD%3A+An+improved+in+vivo+technique+for+CRISPR%2FCas9-based+genetic+manipulations+in+mice%5BTitle%5D)+AND+%22Cells%22%5BJournal%5D)">Sequential i-GONAD: An improved in vivo technique for CRISPR/Cas9-based genetic manipulations in mice.</a> Cells. 9 (3), 546(2020).</li>
<li>Kessler, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+multiple+super-enhancer+region+establishes+inter-TAD+interactions+and+controls+Hoxa+function+in+cranial+neural+crest%5BTitle%5D)+AND+%22Nat+Commun%22%5BJournal%5D)">A multiple super-enhancer region establishes inter-TAD interactions and controls Hoxa function in cranial neural crest.</a> Nat Commun. 14 (1), 3242(2023).</li>
<li>Kaneko, T., Tanaka, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Improvement+of+genome+editing+by+electroporation+using+embryos+artificially+removed+cumulus+cells+in+the+oviducts%5BTitle%5D)+AND+%22Biochem+Biophys+Res+Commun%22%5BJournal%5D)">Improvement of genome editing by electroporation using embryos artificially removed cumulus cells in the oviducts.</a> Biochem Biophys Res Commun. 527 (4), 1039-1042 (2020).</li>
<li>Gurumurthy, C. B., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Creation+of+CRISPR-based+germline-genome-engineered+mice+without+ex+vivo+handling+of+zygotes+by+i-GONAD%5BTitle%5D)+AND+%22Nat+Protoc%22%5BJournal%5D)">Creation of CRISPR-based germline-genome-engineered mice without ex vivo handling of zygotes by i-GONAD.</a> Nat Protoc. 14 (8), 2452-2482 (2019).</li>
<li>Ohtsuka, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((i-GONAD%3A+A+robust+method+for+in+situ+germline+genome+engineering+using+CRISPR+nucleases%5BTitle%5D)+AND+%22Genome+Biol%22%5BJournal%5D)">i-GONAD: A robust method for in situ germline genome engineering using CRISPR nucleases.</a> Genome Biol. 19 (1), 25(2018).</li>
<li>Marshall, O. J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((PerlPrimer%3A+Cross-platform%2C+graphical+primer+design+for+standard%2C+bisulphite+and+real-time+PCR%5BTitle%5D)+AND+%22Bioinformatics%22%5BJournal%5D)">PerlPrimer: Cross-platform, graphical primer design for standard, bisulphite and real-time PCR.</a> Bioinformatics. 20 (15), 2471-2472 (2004).</li>
<li>Truett, G. E., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Preparation+of+PCR-quality+mouse+genomic+DNA+with+hot+sodium+hydroxide+and+Tris+%28HotSHOT%29%5BTitle%5D)+AND+%22BioTechniques%22%5BJournal%5D)">Preparation of PCR-quality mouse genomic DNA with hot sodium hydroxide and Tris (HotSHOT).</a> BioTechniques. 29 (1), 52-54 (2000).</li>
<li>Brinkman, E. K., Van Steensel, B. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Rapid+quantitative+evaluation+of+CRISPR+genome+editing+by+TIDE+and+TIDER%5BTitle%5D)+AND+%22CRISPR+Gene+Editing%22%5BJournal%5D)">Rapid quantitative evaluation of CRISPR genome editing by TIDE and TIDER.</a> CRISPR Gene Editing. 1961, 29-44 (2019).</li>
<li>Imai, Y., Tanave, A., Matsuyama, M., Koide, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Efficient+genome+editing+in+wild+strains+of+mice+using+the+i-GONAD+method%5BTitle%5D)+AND+%22Sci+Rep%22%5BJournal%5D)">Efficient genome editing in wild strains of mice using the i-GONAD method.</a> Sci Rep. 12 (1), 13821(2022).</li>
<li>Iwata, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Simple+and+large-scale+chromosomal+engineering+of+mouse+zygotes+viain+vitro+and+in+vivo+electroporation%5BTitle%5D)+AND+%22Sci+Rep%22%5BJournal%5D)">Simple and large-scale chromosomal engineering of mouse zygotes viain vitro and in vivo electroporation.</a> Sci Rep. 9 (1), 14713(2019).</li>
<li>Abe, M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+novel+technique+for+large-fragment+knock-in+animal+production+without+ex+vivo+handling+of+zygotes%5BTitle%5D)+AND+%22Sci+Rep%22%5BJournal%5D)">A novel technique for large-fragment knock-in animal production without ex vivo handling of zygotes.</a> Sci Rep. 13 (1), 2245(2023).</li>
<li>Meyer-Dilhet, G., Courchet, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((In+utero+cortical+electroporation+of+plasmids+in+the+mouse+embryo%5BTitle%5D)+AND+%22STAR+Protocols%22%5BJournal%5D)">In utero cortical electroporation of plasmids in the mouse embryo.</a> STAR Protocols. 1 (1), 100027(2020).</li>
</ol>

The authors declare no conflicts of interest.

The efficiency of generating knockout mice using the I-GONAD method is comparable to that of traditional microinjection techniques. However, traditional methods involve isolating zygotes from donor females, performing microinjections, and transplanting embryos into the oviducts of pseudo-pregnant females. In contrast, the I-GONAD method simplifies this process by delivering genome-editing components directly into the oviducts of pregnant females, eliminating the need for zygote isolation and transplantation. The presente...

Understanding the genetic basis of diseases is critical for identifying the molecular mechanisms underlying their etiology and pathogenesis. A key step in this research is the development of animal models with targeted gene knockouts that simulate human diseases. Mice are particularly valuable for these studies due to their general genomic similarity to humans, small size, short lifespan, and high fertility. Mice models are important for both basic research and preclinical testing1.
To create a knockout mouse using the CRISPR-Cas9 system, researchers typically inject a complex of guide RNA and Cas9 nuclease into a zygote, causing a double-strand break in the target DNA and thereby activating the cell&#39;s repair system to cause a mutation at the site of the break1,2. Microinjection into zygotes remains the gold standard for this purpose. However, this method requires several steps: isolating embryos from donor females, performing microinjections of genetic constructs into zygotes, and surgically transferring them into the oviducts of pseudo-pregnant females. As a result, maintaining a large number of animals is necessary, including donor females, vasectomized males, and pseudo-pregnant females. Additionally, the isolation of zygotes necessitates the euthanasia of donor females. Therefore, protocols that minimize animal use are preferable, in line with the principles of the 3Rs (Replacement, Reduction, Refinement)3.
Advancements in electroporation technology, such as the use of the Nepa21 system, provide a unique opportunity to generate targeted gene knockout mice in a single step using a technique known as Improved Genome editing via Oviductal Nucleic Acids Delivery (I-GONAD)4. The Super Electroporator NEPA21 Type II employs a 4-step multi-pulse electroporation system, ensuring high electroporation efficiency while maintaining high embryo viability. I-GONAD involves microinjecting CRISPR-Cas components (Cas9 protein (500-600 ng/&#181;l) and guide RNA (80-100 ng/&#181;l)) into the oviducts of pregnant mice 0.7 days after conception, followed by in vivo electroporation to deliver these components directly into zygotes5. After the I-GONAD procedure, the pregnant mouse gives birth to pups with the targeted gene knockout6,7,8. The efficacy of this method varies depending on the desired target, but is comparable with standard microinjection-based techniques (about 50%)9,10. Additionally, I-GONAD could potentially be adapted for genome editing in other species.
This article presents a step-by-step protocol for implementing the I-GONAD method to generate knockout mice. As an example, its effectiveness was demonstrated by targeting the ROSA26 genome locus on mouse chromosome 6. This locus was selected since it undergoes constitutive transcription without subsequent translation. Therefore, introducing a mutation at this locus is unlikely to have a negative effect on the health of the resulting pups.

<table><tbody><tr><td>0.5&amp;ndash;5 uL pipette&amp;nbsp;</td><td>Thermo Scientific</td><td>4642020</td><td></td></tr><tr><td>1.5 mL tube</td><td>Aptaca</td><td>1003/G</td><td></td></tr><tr><td>100-1000 uL pipette&amp;nbsp;</td><td>Thermo Scientific</td><td>4642090</td><td></td></tr><tr><td>200 uL tube</td><td>Axygen</td><td>PCR-02-C</td><td></td></tr><tr><td>20-200 uL pipette&amp;nbsp;</td><td>Thermo Scientific</td><td>4642080</td><td></td></tr><tr><td>2-20 uL pipette&amp;nbsp;</td><td>Thermo Scientific</td><td>4642060</td><td></td></tr><tr><td>4x Gel Loading Dye</td><td>Biolabmix</td><td>D-3002</td><td></td></tr><tr><td>Agarose</td><td>AppliChem</td><td>A8963,0500</td><td></td></tr><tr><td>DNase I, RNase-free (1 U/&amp;mu;L)</td><td>Thermo Fisher</td><td>EN0521</td><td></td></tr><tr><td>dNTP Set, 100 mM Solution</td><td>Thermo Scientific</td><td>R0181</td><td></td></tr><tr><td>DreamTaq Green DNA Polymerase (5 U/&amp;mu;L)</td><td>Thermo Scientific</td><td>EP0713</td><td></td></tr><tr><td>Dulbecco&amp;rsquo;s modified phosphate-buffered saline</td><td>Sigma Aldrich</td><td>D8537</td><td></td></tr><tr><td>EditCo ICE Analysis</td><td>https://ice.editco.bio/#/</td><td></td><td>accessed on 04.06.2025</td></tr><tr><td>EDTA 0.5M solution, pH = 8</td><td>AppliChem</td><td>A4892,0500</td><td></td></tr><tr><td>Ensembl</td><td>&amp;nbsp;https://www.ensembl.org/index.html</td><td></td><td>accessed on 09.06.2025</td></tr><tr><td>Ethidium bromide</td><td>Biolabmix</td><td>EtBr-10</td><td></td></tr><tr><td>Eye gel drops &amp;ldquo;Oftagel&amp;rdquo;</td><td>URSAPHARM</td><td>204604</td><td></td></tr><tr><td>Gel-documenting system ChemiDoc XRS+</td><td>Bio-Rad</td><td>1708265</td><td></td></tr><tr><td>In-Silico PCR V39x1&amp;nbsp;</td><td>https://genome.ucsc.edu/cgi-bin/hgPcr</td><td></td><td>&amp;nbsp;accessed on 09.06.2025</td></tr><tr><td>Integrated DNA Technologies&amp;nbsp;</td><td>https://eu.idtdna.com</td><td></td><td>accessed on 09.06.2025</td></tr><tr><td>Microsurgical scissors</td><td>Medin URAL</td><td>M124</td><td></td></tr><tr><td>NEPA21 electroporator</td><td>Nepa Gene</td><td>NEPA21</td><td>With CUY652P2.5X4 electrode</td></tr><tr><td>NTP Set, 100 mM Solution</td><td>Thermo Scientific</td><td>R0481</td><td></td></tr><tr><td>Oligonucleotides</td><td>Evrogen</td><td></td><td>direct order, standard desalting purification</td></tr><tr><td>Opti-MEM I Reduced Serum Medium</td><td>Thermo Fisher</td><td>31985070</td><td></td></tr><tr><td>PerlPrimer</td><td>https://perlprimer.sourceforge.net</td><td></td><td>Version 1.1.21.</td></tr><tr><td>Phusion High-Fidelity DNA Polymerase (2 U/&amp;mu;L)</td><td>Thermo Scientific</td><td>F530L</td><td></td></tr><tr><td>pipette 10 uL tips</td><td>Ulplast</td><td>HT-10-960</td><td></td></tr><tr><td>pipette 1000 uL tips</td><td>Ulplast</td><td>HT-1000-576</td><td></td></tr><tr><td>pipette 200 uL tips</td><td>Ulplast</td><td>HT-200-960</td><td></td></tr><tr><td>Power supply &amp;ldquo;Elf-4&amp;rdquo;</td><td>DNA-technology</td><td>PS-400 NEW</td><td></td></tr><tr><td>RNAse/DNAse free water</td><td>Invitrogen</td><td>10977049</td><td></td></tr><tr><td>Saline solution</td><td>PanEco</td><td>P011n</td><td></td></tr><tr><td>SE-1 horisontal electrophoresis system</td><td>Helicon</td><td>SE-1</td><td></td></tr><tr><td>Sodium Hydroxide</td><td>Sigma-Aldrich</td><td>S5881-500G</td><td></td></tr><tr><td>Step100 DNA Ladder</td><td>Biolabmix</td><td>S-8100</td><td></td></tr><tr><td>Stereomicroscope SMZ1000</td><td>Nikon</td><td>5-363376</td><td></td></tr><tr><td>Stripper micropipetter</td><td>CooperSurgical</td><td>MXL3-STR</td><td></td></tr><tr><td>Stripper tips</td><td>ORIGIO</td><td>MXL3-125</td><td></td></tr><tr><td>Surgical Needle&amp;nbsp;</td><td>KMIZ</td><td>4A1- 0,6&amp;times;20</td><td></td></tr><tr><td>Suturing forceps</td><td>Medin URAL</td><td>M302.2</td><td></td></tr><tr><td>Suturing forceps</td><td>Medin URAL</td><td>M303</td><td></td></tr><tr><td>Suturing thread POLYCON N&lt;img alt=&quot;Equation 1&quot; src=&quot;/files/ftp_upload/68704/68704eq1.jpg&quot; style=&quot;margin: auto;&quot;/&gt;0</td><td>Tonzos 95</td><td>234</td><td></td></tr><tr><td>SYNTHEGO Knockout Guide Design&amp;nbsp;</td><td>https://design.synthego.com/#/</td><td></td><td>accessed on 09.06.2025</td></tr><tr><td>T100 amplificator</td><td>BioRad</td><td>10014822</td><td></td></tr><tr><td>T7 RNA polymerase&amp;nbsp;</td><td>Thermo Scientific</td><td>EP0111</td><td></td></tr><tr><td>TBE 10x buffer</td><td>Biolabmix</td><td>TBE-500</td><td></td></tr><tr><td>Tide&amp;nbsp;</td><td>https://tide.nki.nl/</td><td></td><td>accessed on 04.06.2025&amp;nbsp;</td></tr><tr><td>Tris hydrochloride</td><td>Suzhou Yacoo Science</td><td>SYS-S0005-0.5</td><td></td></tr><tr><td>Trizma hydrochloride solution</td><td>Sigma Aldrich</td><td>T2663</td><td></td></tr><tr><td>TRIzol Reagent</td><td>Invitrogen</td><td>15596026</td><td></td></tr><tr><td>TrueCut Cas9 Protein</td><td>Invitrogen</td><td>A36499</td><td></td></tr><tr><td>Universal scissors</td><td>Medin URAL</td><td>M147</td><td></td></tr><tr><td>Xylazine</td><td>Interchemie Werken de Adelaar</td><td>IX2</td><td></td></tr><tr><td>Zoletil</td><td>Virbac Lab</td><td>2000443714739.00</td><td></td></tr></tbody></table>

improved genome editing via oviductal nucleic acids delivery-based in vivo electroporation technique for knockout mice generation

Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation

Methods for creating knockout mice typically involve three main steps: (1) collecting embryos from donor females, (2) microinjecting genetic constructs into the zygotes ex vivo, and (3) surgically transferring them into the oviduct of pseudo-pregnant females. This process requires a significant number of animals, as it involves not only donor females but also vasectomized males and pseudo-pregnant females. Moreover, microinjections into the cytoplasm or pronucleus of mouse zygotes present challenges such as needle clogging, membrane permeability issues due to high elasticity, and potential embryo death. The development of advanced electroporators, such as the Nepa21, provides a unique opportunity to generate mice with targeted gene knockouts in a single step through a method known as Improved Genome Editing via Oviductal Nucleic Acids Delivery (I-GONAD). This technique involves microinjecting CRISPR-Cas components (Cas9 protein and guide RNA) into the oviducts of pregnant females at 0.7 days post-conception, followed by in vivo electroporation to deliver these components directly into the zygotes. Following the I-GONAD procedure, the pregnant mouse carries and gives birth to pups with the targeted gene knockout. This article provides a detailed, step-by-step protocol for implementing the I-GONAD method in mice, offering a more efficient and accessible alternative to traditional knockout mouse generation techniques.

If the electroporation was successful, the experimental mice will: (1) give birth to a handful of pups, and (2) some animals will have different indels in the genome. If the genotyping primers are well-designed, and the PCR program is optimal, the PCR product will be present on the agarose gel as one clear band of the desired size. If the nuclease successfully cuts the target DNA, then the obtained animals will likely be mosaic and have a range of indels in the genome. Computational tools, such as EditCo ICE Analysis or ...

The efficiency of the Improved Genome Editing via Oviductal Nucleic Acids Delivery (I-GONAD) method is comparable to traditional microinjection, which requires zygote collection from donor females and transfer to pseudo-pregnant females. This protocol demonstrates its effectiveness by introducing CRISPR/Cas9-induced mutations into the ROSA26 locus on chromosome 6.

Methods for creating knockout mice typically involve three main steps: (1) collecting embryos from donor females, (2) microinjecting genetic constructs ...

The scope of our research is to simplify the generation of knockout mice by using in utero electroporation, delivering genome editing components directly into the oviducts of pregnant females. Micro-injections into zygotes requires maintaining a large number of animals including donor and recipient females and vasectomized males. Therefore, protocols that minimize animal use are preferable.The use of Nepa21 system for zygote electroporation provides a unique opportunity to generate targeted gene knockout mice in a single step, with efficiency comparable to standard nuclear injection-based techniques To begin, use computational analysis tools to identify potential single guide RNA sequences targeting the selected gene of interest. Select sequences located in exons that are as close as possible to the desired mutation site. Use a genome browser to cross-reference exome structure and prioritize sequences present in most splice isoforms.Analyze the predicted off-target activity of each guide sequence using the tool's integrated scoring system. Choose sequences that demonstrate the lowest likelihood of off-target binding. To produce a linear double-stranded DNA template, prepare the PCR master mix using the components specified in the given table.Add the polymerase last and keep the master mix on ice to preserve enzymatic stability. Then, run the PCR using the following thermal cycling conditions. Next, prepare the in vitro transcription master mix using the given components and incubate the reaction for 1.5 hours at 37 degrees Celsius using a thermocycler for consistent temperature control.Then, add two microliters of DNase I to the reaction. Incubate at 37 degrees Celsius for an additional 30 minutes to digest the DNA template, and then inactivate the enzyme at 75 degrees Celsius for five minutes. After TRIzol purification of RNA, measure the RNA concentration using a spectrophotometer and check the A260 to A280 and A260 to A230 ratios.To prepare the ribonucleoprotein complex for transfection, dilute one molar Tris-HCl buffer to a concentration of 100 millimolar using nuclease-free water. Filter the solution using a syringe filter with a 0.022 micrometer pore size. Aliquot into 10 microliter portions and store at four degrees Celsius until use.Next, prepare the transfection mix using spCas9 nuclease, single guide RNA, and Tris-HCl diluted with DEPC water in a nuclease-free tube. Incubate the transfection mix at 37 degrees Celsius for 10 minutes to allow formation of the ribonucleoprotein complex. Then, aliquot the transfection mix into small volumes suitable for single I-GONAD sessions and keep it at four degrees Celsius to preserve reagent activity.After mating CD1 female mice with single-housed CD1 male mice overnight, check each female for the presence of a copulation plug. Transfer only those females with visible plugs into a new cage for further experimental procedures. Autoclave all stainless steel surgical instruments to ensure sterility before use.Then, weigh the selected plug=positive female mice using an electronic scale before anesthetizing them. Monitor the anesthetized mice for loss of the toe pinch reflex to confirm adequate anesthesia. Place the mouse on a heating pad to maintain body temperature during the procedure.Then, apply veterinary ointment to the eyes to prevent dryness. Using fine scissors, make a 0.7 centimeter longitudinal incision in the skin of the lower back region. Then, laterally spread the slightly open tips of the scissors to gently extend the skin incision to approximately 1.3 centimeters.After that, carefully make a 0.7 centimeter incision in the peritoneum to expose the abdominal cavity. Extend the peritoneal incision to 1.1 centimeters, bilaterally pushing with slightly open scissor tips. Locate the fat pad connected to the ovary and gently pull it outward using forceps until the ovary, oviduct, and uterus are exposed.Using a vessel clamp, secure the fat pad to stabilize the reproductive structures. Next, load two microliters of the ribonucleoprotein injection mix into a disposable plastic capillary using a stripper pipetter. Using micro scissors, make a 0.2 centimeter incision in the oviduct wall a few millimeters upstream of the ampulla.Insert the plastic capillary attached to the stripper pipetter into the oviduct incision and carefully expel the injection mix without introducing air. Gently withdraw the plastic capillary from the oviduct to complete the injection. Turn on the electroporator by pressing the power switch on the front panel.Set the electroporation parameters on the device as shown on the screen. Using tweezer-type electrodes, gently grasp the oviduct and press the Kiloohm button to measure the resistance. Immediately after resistance measurement, press the Start button to begin electroporation and wait for the end signal to appear on the Ohm button.After electroporation of the first oviduct, gently return the reproductive tract to the abdominal cavity. Close the incision using 4-0 polyglycolic acid surgical suture. For genotyping, design 18 to 21 nucleotide long primers with a melting temperature near 60 degrees Celsius to generate a 300 to 600 base pair PCR product.To confirm the specificity of each primer, perform a BLAST search against the mouse genome database to eliminate the risk of non-specific amplification. Next, for DNA extraction, using an ear punch, collect a small tissue sample approximately two millimeters in size from the mouse's ear. Add 100 microliters of lysis buffer.Incubate the sample at 95 degrees Celsius for 60 minutes, vortexing every 20 minutes to ensure efficient lysis. After performing Sanger sequencing, analyze the results to assess genome editing outcomes. To use ICE analysis, upload both the Sanger sequencing files, enter the guide RNA sequence, and select the appropriate nuclease used in the CRISPR experiment.Next, to use TIDE, upload the control and experimental sequencing files in AB1 format and enter the guide RNA sequence. ICE analysis detected three distinct indel variants at the Cas9 cut site, a one base pair deletion in 42%of sequences, a three base pair deletion in 25%of sequences, and a 23 base pair deletion in 27%of sequences. The model fit value was 0.94 and the knockout score was 69, indicating a strong predicted correlation and likely gene knockout.Sequence chromatograms confirmed disruption at the Cas9 cut site in the edited sample, whereas the control chromatogram showed an intact sequence at the same site. Out of six electroporated mice, only four produced pups with mutations, resulting in a 60%overall editing efficiency. All litters across the six electroporated mice showed reduced pup numbers, with only three to four pups per mouse.

improved-genome-editing-via-oviductal-nucleic-acids-delivery-based

Research

JoVE Journal

Genetics

To assess the function and the regulation of genes during the development of midbrain dopaminergic neurons, we describe a method that involves in ovo electroporation of plasmid DNA constructs into embryonic chick ventral midbrain dopaminergic neuron progenitors. This technique can be used to achieve efficient expression of genes of interest to study different aspects of midbrain development and dopaminergic neuron differentiation.

In ovo Electroporation in Chick Midbrain for Studying Gene Function in Dopaminergic Neuron Development

Designer nucleases such as zinc finger nucleases (ZFNs) and transcription activator-like effector nucleases (TALENs) can be used to modify the genome of mouse preimplantation embryos by triggering both the nonhomologous end joining (NHEJ) and homologous recombination (HR) pathways. These advances enable the rapid generation of mice with precise genetic modifications.

Mouse Genome Engineering Using Designer Nucleases

The microinjection of mouse oocytes is commonly used for both classic transgenesis (i.e., the random integration of transgenes) and CRISPR-mediated gene targeting. This protocol reviews the latest developments in microinjection, with a particular emphasis on quality control and genotyping strategies.

Generation of Genetically Modified Mice through the Microinjection of Oocytes

Here, we present a modified method for cryopreservation of one-cell embryos as well as a protocol that couples the use of freeze-thawed embryos and electroporation for the efficient generation of genetically modified mice.

Use of Freeze-thawed Embryos for High-efficiency Production of Genetically Modified Mice

The present protocol describes zygote microinjection of CRISPR-Cas9 and donor DNA to efficiently produce gene cassette knock-in and floxed mice.

Zygote Microinjection for Creating Gene Cassette Knock-in and Flox Alleles in Mice

Here, we describe a simple technique intended for the efficient generation of genetically modified mice called CRISPR RNP Electroporation of Zygotes (CRISPR-EZ). This method delivers editing reagents by electroporation into embryos at an efficiency approaching 100%. This protocol is effective for point mutations, small genomic insertions, and deletions in mammalian embryos.

Efficient Genome Editing of Mice by CRISPR Electroporation of Zygotes

Here we present a protocol for developing genetically modified mouse models using embryonic stem cells, especially for large DNA knock-in (KI). This protocol is tuned up using CRISPR/Cas9 genome editing, resulting in significantly improved KI efficiency compared with the conventional homologous recombination-mediated linearized DNA targeting method.

CRISPR/Cas9-Mediated Highly Efficient Gene Targeting in Embryonic Stem Cells for Developing Gene-Manipulated Mouse Models

This protocol describes microinjection and in vivo electroporation for regionally restricted CRISPR-mediated genome editing in the mouse oviduct.

Somatic Genome-Engineered Mouse Models Using In Vivo Microinjection and Electroporation

This protocol presents an optimized approach for producing genetically modified rat models. Adeno-associated virus (AAV) is used to deliver a DNA repair template, and electroporation is used to deliver CRISPR-Cas9 reagents to complete the genome editing process in 2-cell embryo.

CRISPR-Cas9 Genome Editing of Rat Embryos using Adeno-Associated Virus (AAV) and 2-Cell Embryo Electroporation

The delivery of genome editors as RNAs is a particularly potent means of modifying the genomes of primary mammalian cells and cell lines. The goal of this protocol is to deliver genome editors as mRNA into primary mammalian cells and cell lines, followed by targeted Illumina sequencing and analysis to quantify editing outcomes.

Genome Editing in Primary Mammalian Cells via Electroporation of Editor RNA

Discover the I-GONAD method for generating knockout mice using in utero electroporation and CRISPR/Cas9 technology. This approach reduces animal use while achieving efficiency comparable to traditional microinjection techniques.

Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation (Video) | JoVE Journal

Improved Genome Editing via Oviductal Nucleic Acids Delivery-based In Vivo Electroporation Technique for Knockout Mice Generation

Explore More Videos